GENE ONLINE|News &
Opinion
Blog

2024-03-28|

Previewing AACR 2024 With Select Pre-Meeting Highlights

by Bernice Lottering
Share To
Source: AACR

American Association for Cancer Research, 2024 Annual Meeting

The AACR Annual Meeting 2024 is scheduled to take place at the San Diego Convention Center in California, running from April 5th to April 10th. Taking place every year, the AACR Annual Meeting serves as the central hub for the cancer research community, bringing together scientists, clinicians, healthcare professionals, survivors, patients, and advocates to exchange the most recent breakthroughs in cancer science and medicine. This year’s rich program spans the breadth of oncology, encompassing advancements in population science, prevention, cancer biology, translational and clinical studies, as well as survivorship and advocacy. It showcases the innovative work of leading researchers and medical professionals from institutions across the globe.

GeneOnline will conduct a special report on the AACR. The following table is a preview of some of the exciting content to be shared.

2024 AACR Select Research Highlights by Oscar Wu, GeneOnline

With approximately 22 000 attendees, 630 speakers and 450 exhibitors, present throughout the 6 day conference, the AACR Annual meeting promises to be a rich source of information within the oncology field. Featuring educational conferences, specialized courses, workshop lectures, special forums and educational materials, this ground-breaking comprehensive content is something not to be missed.

Reference: AACR Official Website

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
2024-04-10
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top